Literature DB >> 7769713

Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus.

M J van Lierop1, J P Wagenaar, J M van Noort, E J Hensen.   

Abstract

Although VP1 region 140 to 160 of foot-and-mouth disease virus (FMDV) is able to elicit neutralizing antibody in cattle, the protection against virus challenge that is conferred by peptide immunization is often poor. Here, we show that bovine T cells primed with peptides derived from this region generally show no reactivity to intact FMDV. In contrast, T-cell epitope VP4[20-34] is able to prime for a virus-specific response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769713      PMCID: PMC189195          DOI: 10.1128/JVI.69.7.4511-4514.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Protection of cattle against foot-and-mouth disease by a synthetic peptide.

Authors:  R DiMarchi; G Brooke; C Gale; V Cracknell; T Doel; N Mowat
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

2.  Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.

Authors:  M J Francis; G Z Hastings; A D Syred; B McGinn; F Brown; D J Rowlands
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

3.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.

Authors:  J L Bittle; R A Houghten; H Alexander; T M Shinnick; J G Sutcliffe; R A Lerner; D J Rowlands; F Brown
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

4.  Immune response to uncoupled peptides of foot-and-mouth disease virus.

Authors:  M J Francis; C M Fry; D J Rowlands; J L Bittle; R A Houghten; R A Lerner; F Brown
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

5.  Polymorphism of bovine MHC class II genes. Joint report of the Fifth International Bovine Lymphocyte Antigen (BoLA) Workshop, Interlaken, Switzerland, 1 August 1992.

Authors:  C J Davies; I Joosten; L Andersson; M A Arriens; D Bernoco; B Bissumbhar; G Byrns; M J van Eijk; B Kristensen; H A Lewin
Journal:  Eur J Immunogenet       Date:  1994-08

6.  Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.

Authors:  P Zamorano; A Wigdorovitz; M T Chaher; F M Fernandez; C Carrillo; F E Marcovecchio; A M Sadir; M V Borca
Journal:  Virology       Date:  1994-06       Impact factor: 3.616

7.  Location and characterization of the antigenic portion of the FMDV immunizing protein.

Authors:  K Strohmaier; R Franze; K H Adam
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

8.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

9.  Immunological priming with synthetic peptides of foot-and-mouth disease virus.

Authors:  M J Francis; C M Fry; D J Rowlands; F Brown; J L Bittle; R A Houghten; R A Lerner
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

10.  The influence of MHC polymorphism on the selection of T-cell determinants of FMDV in cattle.

Authors:  M J Van Lierop; P R Nilsson; J P Wagenaar; J M Van Noort; J D Campbell; E J Glass; I Joosten; E J Hensen
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

View more
  12 in total

1.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

2.  A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.

Authors:  O Taboga; C Tami; E Carrillo; J I Núñez; A Rodríguez; J C Saíz; E Blanco; M L Valero; X Roig; J A Camarero; D Andreu; M G Mateu; E Giralt; E Domingo; F Sobrino; E L Palma
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus.

Authors:  E Blanco; M Garcia-Briones; A Sanz-Parra; P Gomes; E De Oliveira; M L Valero; D Andreu; V Ley; F Sobrino
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4.

Authors:  E Blanco; K McCullough; A Summerfield; J Fiorini; D Andreu; C Chiva; E Borrás; P Barnett; F Sobrino
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.

Authors:  Jun-Jun Shao; Chung Kai Wong; Tong Lin; Shuk Kwan Lee; Guo-Zheng Cong; Fion Wai Yee Sin; Jun-Zheng Du; Shan-Dian Gao; Xiang-Tao Liu; Xue-Peng Cai; Yong Xie; Hui-Yun Chang; Ji-Xing Liu
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

6.  High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli.

Authors:  Joon-Goo Jung; Yong Jae Lee; Natarajan Velmurugan; Young-Joon Ko; Hyang-Sim Lee; Ki Jun Jeong
Journal:  J Ind Microbiol Biotechnol       Date:  2013-04-26       Impact factor: 3.346

7.  Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes.

Authors:  Wilhelm Gerner; Sabine E Hammer; Karl-Heinz Wiesmüller; Armin Saalmüller
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice.

Authors:  Ji-Young Bae; Sun-Hwa Moon; Jung-Ah Choi; Jong-Sug Park; Bum-Soo Hahn; Ki-Yong Kim; Byunghan Kim; Jae-Young Song; Dae-Hyuck Kwon; Suk-Chan Lee; Jong-Bum Kim; Joo-Sung Yang
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

9.  Interferon-γ induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection.

Authors:  Yooni Oh; Lucy Fleming; Bob Statham; Pip Hamblin; Paul Barnett; David J Paton; Jong-Hyeon Park; Yi Seok Joo; Satya Parida
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

10.  Antigenicity and Immunogenicity Analysis of the E. coli Expressed FMDV Structural Proteins; VP1, VP0, VP3 of the South African Territories Type 2 Virus.

Authors:  Guoxiu Li; Ashenafi Kiros Wubshet; Yaozhong Ding; Qian Li; Junfei Dai; Yang Wang; Qian Hou; Jiao Chen; Bing Ma; Anna Szczotka-Bochniarz; Susan Szathmary; Yongguang Zhang; Jie Zhang
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.